États-Unis · Plateformes & données · MarketBeat

Ionis Pharmaceuticals (NASDAQ:IONS) Shares Down 7.3% on Analyst Downgrade

Publié par MarketBeat · États-Unis il y a 50 min

Image from MarketBeat Media, LLC. · MarketBeat

Résumé détaillé

Ionis Pharmaceuticals (NASDAQ:IONS) Stock Falls 7.3% After Analyst Downgrade

Lire l'article complet sur MarketBeat Connectez-vous pour sauvegarder

MarketNews présente le titre et le résumé publiés par le média. L'article complet se lit sur le site de l'éditeur. (www.marketbeat.com)

À lire aussi

Harrow stock jumps as eye-care products deliver record Q3 sales

The Motley Fool

Fed Governor Christopher Waller Just Said 21 Words That Could Challenge the Stock Market Through Year End

‘We had the worst fight’: I want my husband to retire at 65, but I don’t want to lose his $280,000 salary. Is that unreasonable?

Earnings call transcript: Safe Bulkers tops Q3 2026 estimates as shares rise

Toncoin (TON) Price Prediction 2025, 2026, 2027-2030

Polymarket says annualized revenue has topped $1.8 billion